NASDAQ:ANIP
ANI Pharmaceuticals Stock News
$61.43
-2.34 (-3.67%)
At Close: May 17, 2024
ANI Pharmaceuticals Reports First Quarter 2021 Results
06:50am, Friday, 07'th May 2021
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three months ended March 3
SNDL Stock Is Need Of a Growth Story and Positive Catalysts
03:47pm, Monday, 03'rd May 2021
SNDL stock has fallen considerably from February highs of $4, but it lacks company-specific catalysts for long-term sustainable success. The post SNDL Stock Is Need Of a Growth Story and Positive Cata
Earnings Preview: ANI Pharmaceuticals (ANIP) Q1 Earnings Expected to Decline
03:46pm, Friday, 30'th Apr 2021
ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ANI Pharmaceuticals Expands Branded Products Portfolio Through Acquisition of Sandoz Inc. NDAs
06:50am, Tuesday, 06'th Apr 2021
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ:ANIP) today announced that it has acquired the new drug applications (“NDAs”) for OXISTAT® Lotion, VEREGEN® Ointme
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2020 Results - Earnings Call Transcript
03:06pm, Tuesday, 09'th Mar 2021
ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2020 Results - Earnings Call Transcript
ANI Pharmaceuticals (ANIP) Q4 Earnings Miss Estimates
09:06am, Tuesday, 09'th Mar 2021
ANI (ANIP) delivered earnings and revenue surprises of -20.00% and 3.91%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results; Company Positioned for Sustainable Future Growth
06:50am, Tuesday, 09'th Mar 2021
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced business highlights and financial results for the three and 12 months ended
ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business
06:45am, Tuesday, 09'th Mar 2021
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that it has signed a definitive agreement to acquire Novitium Pharma, a priv
ANI Pharmaceuticals's Earnings: A Preview
10:18am, Monday, 08'th Mar 2021
ANI Pharmaceuticals (NASDAQ:ANIP) announces its next round of earnings this Tuesday, March 09. Here is Benzinga's everything-that-matters guide for this Tuesday's Q4 earnings announcement.
Earnings Preview: ANI Pharmaceuticals (ANIP) Q4 Earnings Expected to Decline
01:38pm, Tuesday, 02'nd Mar 2021
ANI (ANIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ANI Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 19'th Feb 2021
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI“ or the “Company“) (Nasdaq: ANIP) today announced that ANI's Board of Directors granted non-qualified inducement stock options
ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth
06:50am, Wednesday, 17'th Feb 2021
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the addition of three key pharmaceutical executives: Christopher K. Mutz as
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021
04:30pm, Tuesday, 16'th Feb 2021
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2020 financia
ANI Pharmaceuticals Announces Launch of Prazosin Hydrochloride (“HCl”) Capsules
06:50am, Monday, 01'st Feb 2021
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Prazosin HCl Capsules USP, 1mg and 2mg, following the U.S. Foo
ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid Tablets
06:50am, Thursday, 17'th Dec 2020
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval and the launch of Aminocapr